Bladder cancer battle: which chemo combo wins before or after surgery?
NCT ID NCT01812369
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study tested two chemotherapy combinations in 500 bladder cancer patients to see which works better before or after bladder removal surgery. One group received gemcitabine plus cisplatin, the other a high-dose version of MVAC. The goal was to see which regimen delays cancer progression longer. Results help doctors choose the best perioperative treatment for locally advanced bladder cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UHRouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.